These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 37867315)
1. A Case Report of Oral Bisphosphonate Treatment for Osteoporosis Leading to Atypical Femoral Fracture and Pathologic Mandibular Fracture. Fernandes TL; Viezzer Fernandes B; Jitumori C; Franco GCN Am J Case Rep; 2023 Oct; 24():e941144. PubMed ID: 37867315 [TBL] [Abstract][Full Text] [Related]
2. Osteonecrosis of the jaw (ONJ) and atypical femoral fracture (AFF) in an osteoporotic patient chronically treated with bisphosphonates. Sánchez A; Blanco R Osteoporos Int; 2017 Mar; 28(3):1145-1147. PubMed ID: 27866217 [TBL] [Abstract][Full Text] [Related]
3. Atypical femoral fractures shortly after osteonecrosis of the jaw in a postmenopausal woman taking alendronate for osteoporosis. Chiu WY; Lee JJ; Tsai KS J Clin Endocrinol Metab; 2013 Apr; 98(4):E723-6. PubMed ID: 23471975 [TBL] [Abstract][Full Text] [Related]
4. Unusual case of a conservatively treated pathological fracture after sequestrectomy in a patient with long-term oral bisphosphonate use. Kuijpers SC; van Roessel EW; van Merkesteyn JP J Craniomaxillofac Surg; 2011 Jan; 39(1):69-72. PubMed ID: 20435482 [TBL] [Abstract][Full Text] [Related]
5. The 5-year follow-up of a cortical stress fracture resulting in a spontaneous atypical subtrochanteric femoral fracture in a female patient with severe osteoporosis and bisphosphonate therapy over 15 years. Haschka J; Kühne F; Muschitz C; Pirker T; Kocijan R; Bittighofer C; Trubrich A; Resch H Wien Klin Wochenschr; 2011 Nov; 123(21-22):684-7. PubMed ID: 21837437 [TBL] [Abstract][Full Text] [Related]
6. ATYPICAL FEMORAL FRACTURES AFTER LONG-TERM BISPHOSPHONATES THERAPY: CASE REPORT. Găleşanu C; Mocanu V; Buzdugă C; Florescu A; Zaharia V; Lisnic V Rev Med Chir Soc Med Nat Iasi; 2016; 120(1):114-8. PubMed ID: 27125082 [TBL] [Abstract][Full Text] [Related]
7. Teriparatide treatment in an adult patient with hypophosphatasia exposed to bisphosphonate and revealed by bilateral atypical fractures. Righetti M; Wach J; Desmarchelier R; Coury F Joint Bone Spine; 2018 May; 85(3):365-367. PubMed ID: 29246529 [TBL] [Abstract][Full Text] [Related]
8. Can long-term bisphosphonate use causes low-energy fractures? A case report. Dandinoğlu T; Akarsu S; Karadeniz M; Tekin L; Arıbal S; Kıralp MZ Osteoporos Int; 2014 Feb; 25(2):773-6. PubMed ID: 23824297 [TBL] [Abstract][Full Text] [Related]
9. Differences in bone histomorphometry between White postmenopausal women with and without atypical femoral fracture after long-term bisphosphonate therapy. Qiu S; Dhaliwal R; Divine G; Warner E; Rao SD J Bone Miner Res; 2024 May; 39(4):417-424. PubMed ID: 38477744 [TBL] [Abstract][Full Text] [Related]
10. MANAGEMENT OF ENDOCRINE DISEASE: Atypical femoral fractures: risks and benefits of long-term treatment of osteoporosis with anti-resorptive therapy. Adler RA Eur J Endocrinol; 2018 Mar; 178(3):R81-R87. PubMed ID: 29339529 [TBL] [Abstract][Full Text] [Related]
11. Successful teriparatide treatment of atypical fracture after long-term use of alendronate without surgical procedure in a postmenopausal woman: a case report. Huang HT; Kang L; Huang PJ; Fu YC; Lin SY; Hsieh CH; Chen JC; Cheng YM; Chen CH Menopause; 2012 Dec; 19(12):1360-3. PubMed ID: 22968250 [TBL] [Abstract][Full Text] [Related]
12. Retrospective review of patients with atypical bisphosphonate related proximal femoral fractures. Phillips HK; Harrison SJ; Akrawi H; Sidhom SA Injury; 2017 Jun; 48(6):1159-1164. PubMed ID: 28410753 [TBL] [Abstract][Full Text] [Related]
13. Bisphosphonate-associated atypical subtrochanteric femur fractures in the older patient. Gopal GK; Tam KL; Krishnan SP; Maddern IL N Z Med J; 2014 Feb; 127(1389):81-5. PubMed ID: 24548959 [TBL] [Abstract][Full Text] [Related]
14. Patients Receiving Parenteral Bisphosphonates for Malignant Disease and Having Developed an Atypical Femoral Fracture Are at Risk of Concomitant Osteonecrosis of the Jaw: An Evidence-Based Review. Graves LL; Bukata SV; Aghazadehsanai N; Chang TI; Garrett NR; Friedlander AH J Oral Maxillofac Surg; 2016 Dec; 74(12):2403-2408. PubMed ID: 27376180 [TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics, densitometric parameters and outcomes of patients with atypical femoral fractures related to bisphosphonate treatment for osteoporosis. Wong CH; Kan AKC; Tsoi KH; Chan SSY; Jiang NS; Loong CHN; Fong CHY; Wong JSH; Shea GKH; Cheung CL; Lee CH; Tan KCB; Woo YC; Lui DTW Endocrine; 2024 Apr; 84(1):223-235. PubMed ID: 37985574 [TBL] [Abstract][Full Text] [Related]
16. Long-Term Drug Therapy and Drug Discontinuations and Holidays for Osteoporosis Fracture Prevention: A Systematic Review. Fink HA; MacDonald R; Forte ML; Rosebush CE; Ensrud KE; Schousboe JT; Nelson VA; Ullman K; Butler M; Olson CM; Taylor BC; Brasure M; Wilt TJ Ann Intern Med; 2019 Jul; 171(1):37-50. PubMed ID: 31009947 [TBL] [Abstract][Full Text] [Related]
17. Healing of bisphosphonate-associated atypical femoral fractures in patients with osteoporosis: a comparison between treatment with and without teriparatide. Miyakoshi N; Aizawa T; Sasaki S; Ando S; Maekawa S; Aonuma H; Tsuchie H; Sasaki H; Kasukawa Y; Shimada Y J Bone Miner Metab; 2015 Sep; 33(5):553-9. PubMed ID: 25227287 [TBL] [Abstract][Full Text] [Related]
18. Bilateral atypical femoral fractures after long-term alendronate therapy: a case report. Bamrungsong T; Pongchaiyakul C J Med Assoc Thai; 2010 May; 93(5):620-4. PubMed ID: 20524451 [TBL] [Abstract][Full Text] [Related]
19. Low-energy femoral fractures associated with the long-term use of bisphosphonates: a case series from a Swiss university hospital. Ing-Lorenzini K; Desmeules J; Plachta O; Suva D; Dayer P; Peter R Drug Saf; 2009; 32(9):775-85. PubMed ID: 19670917 [TBL] [Abstract][Full Text] [Related]
20. High bisphosphonate treatment rates and the prevalence of atypical femoral fractures in patients with systematic lupus erythematosus: a single-center retrospective study performed in Japan. Sato H; Kondo N; Wakamatsu A; Kobayashi D; Nakatsue T; Wada Y; Kuroda T; Suzuki Y; Nakano M; Endo N; Narita I Rheumatol Int; 2019 Oct; 39(10):1803-1810. PubMed ID: 31385078 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]